cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Rhythm Pharmaceuticals Inc
3 own
12 watching
Current Price
$28.63
$-0.27
(-0.93%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,596.3M
52-Week High
52-Week High
34.99
52-Week Low
52-Week Low
3.04
Average Volume
Average Volume
0.37M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
82.6448
iconMarket Capitalization1,596.3M
icon52-Week High34.99
icon52-Week Low3.04
iconAverage Volume0.37M
iconDividend Yield--
iconP/E Ratio82.6448
What does the Rhythm Pharmaceuticals Inc do?
N/A
Read More
How much money does Rhythm Pharmaceuticals Inc make?
News & Events about Rhythm Pharmaceuticals Inc.
Globe Newswire
12days ago
- Patients reported clinically meaningful improvements across multiple health-related quality of life measures following 52 weeks of treatment with setmelanotide - - Analysis published in Orphanet Journal of Rare Diseases - BOSTON, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (...
Ticker Report
14days ago
Canaccord Genuity Group reiterated their buy rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM Get Rating) in a report issued on Wednesday, Benzinga reports. A number of other equities analysts have also weighed in on RYTM. The Goldman Sachs Group upped their target price on shares of ...
Globe Newswire
2 months ago
BOSTON, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway ...
Globe Newswire
2 months ago
-- Health Canada accepts for review new drug submission for setmelanotide for the treatment of obesity and control of hunger in BBS and biallelic POMC, PCSK1 and LEPR deficiencies -- BOSTON, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage ...
Globe Newswire
4 months ago
Understanding Hunger & Bardet-Biedl Syndrome (BBS): Gabes Story Developed in collaboration with the Bardet-Biedl Syndrome (BBS) Foundation -- Book developed in collaboration with the Bardet-Biedl Syndrome Foundation -- -- BBS Global Day on Sept. 24 coordinated by BBS International -- BOSTON, Sept...
Frequently Asked Questions
Frequently Asked Questions
What is Rhythm Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Rhythm Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Rhythm Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Rhythm Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Rhythm Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Rhythm Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Rhythm Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Rhythm Pharmaceuticals Inc?
plus_minus_icon
What percentage is Rhythm Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Rhythm Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$28.63
$-0.27
(-0.93%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00